Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP613131.RAEmJOtuuSjpXTZvTReuuA4iN2hHfXoco9IpO-EpqGbZA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP613131.RAEmJOtuuSjpXTZvTReuuA4iN2hHfXoco9IpO-EpqGbZA130_assertion type Assertion NP613131.RAEmJOtuuSjpXTZvTReuuA4iN2hHfXoco9IpO-EpqGbZA130_head.
- NP613131.RAEmJOtuuSjpXTZvTReuuA4iN2hHfXoco9IpO-EpqGbZA130_assertion description "[We have employed chimeric antisense oligonucleotides to investigate the molecular alterations after targeted interference with Plk1 in RKO human colon adenocarcinoma and PC3 prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613131.RAEmJOtuuSjpXTZvTReuuA4iN2hHfXoco9IpO-EpqGbZA130_provenance.
- NP613131.RAEmJOtuuSjpXTZvTReuuA4iN2hHfXoco9IpO-EpqGbZA130_assertion evidence source_evidence_literature NP613131.RAEmJOtuuSjpXTZvTReuuA4iN2hHfXoco9IpO-EpqGbZA130_provenance.
- NP613131.RAEmJOtuuSjpXTZvTReuuA4iN2hHfXoco9IpO-EpqGbZA130_assertion SIO_000772 16648550 NP613131.RAEmJOtuuSjpXTZvTReuuA4iN2hHfXoco9IpO-EpqGbZA130_provenance.
- NP613131.RAEmJOtuuSjpXTZvTReuuA4iN2hHfXoco9IpO-EpqGbZA130_assertion wasDerivedFrom befree-20140225 NP613131.RAEmJOtuuSjpXTZvTReuuA4iN2hHfXoco9IpO-EpqGbZA130_provenance.
- NP613131.RAEmJOtuuSjpXTZvTReuuA4iN2hHfXoco9IpO-EpqGbZA130_assertion wasGeneratedBy ECO_0000203 NP613131.RAEmJOtuuSjpXTZvTReuuA4iN2hHfXoco9IpO-EpqGbZA130_provenance.